AsiaIntervention最新文献

筛选
英文 中文
In-stent neoatherosclerosis: a new problem or an opportunity to rethink the treatment of coronary disease? 支架内新动脉粥样硬化:新问题还是重新思考冠心病治疗的契机?
AsiaIntervention Pub Date : 2024-09-27 eCollection Date: 2024-09-01 DOI: 10.4244/AIJ-E-24-00006
Gian Paolo Ussia, Nino Cocco
{"title":"In-stent neoatherosclerosis: a new problem or an opportunity to rethink the treatment of coronary disease?","authors":"Gian Paolo Ussia, Nino Cocco","doi":"10.4244/AIJ-E-24-00006","DOIUrl":"https://doi.org/10.4244/AIJ-E-24-00006","url":null,"abstract":"","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11413636/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142336712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OCT-based comparative evaluation of culprit lesion morphology in very young versus older adult patients with STEMI. 基于光学视网膜成像技术对 STEMI 患者中年轻患者和老年患者的罪魁祸首病变形态进行比较评估。
AsiaIntervention Pub Date : 2024-09-27 eCollection Date: 2024-09-01 DOI: 10.4244/AIJ-D-24-00013
M P Girish, Mohit D Gupta, Akiko Maehara, Mitsuaki Matsumura, Ankit Bansal, Shekhar Kunal, Vishal Batra, Arun Mohanty, Arman Qamar, Gary S Mintz, Ziad A Ali, Jamal Yusuf
{"title":"OCT-based comparative evaluation of culprit lesion morphology in very young versus older adult patients with STEMI.","authors":"M P Girish, Mohit D Gupta, Akiko Maehara, Mitsuaki Matsumura, Ankit Bansal, Shekhar Kunal, Vishal Batra, Arun Mohanty, Arman Qamar, Gary S Mintz, Ziad A Ali, Jamal Yusuf","doi":"10.4244/AIJ-D-24-00013","DOIUrl":"https://doi.org/10.4244/AIJ-D-24-00013","url":null,"abstract":"<p><strong>Background: </strong>The clinical and pathophysiological characteristics of coronary artery disease in very young adults are poorly described.</p><p><strong>Aims: </strong>Using optical coherence tomography (OCT), we compared culprit lesion morphology in very young adult patients (≤35 years) versus older adult patients (>60 years) with ST-segment elevation myocardial infarction (STEMI).</p><p><strong>Methods: </strong>Culprit lesion morphology was classified as plaque rupture, plaque erosion, or calcified nodule. Thrombus age was subclassified into acute (intraluminal thrombus with surface irregularity) or subacute (mostly mural thrombus with a smooth surface).</p><p><strong>Results: </strong>A total of 61 patients who underwent thrombolysis within 24 hours from symptom onset were included, with 38 (59.7%) subjects ≤35 years and 23 (40.3%) subjects >60 years of age. As an underlying mechanism of STEMI thrombosis, plaque erosion was more common in very young patients (52.6% vs 21.7%; p=0.02) while plaque rupture was more common in elderly patients (65.2% vs 36.8%; p=0.03). Acute or subacute thrombus was identified in 68.9% (42/61) of patients, with red thrombus being more frequent in very young patients. In the entire patient cohort, acute thrombus was more frequent in plaque rupture compared with plaque erosion (62.0% vs 28.0%; p=0.01), whereas subacute thrombus was more common in plaque erosion versus plaque rupture (52.0% vs 10.3%; p=0.0008).</p><p><strong>Conclusions: </strong>OCT showed that plaque erosion and plaque rupture were the most common underlying STEMI mechanisms in very young patients and older patients, respectively, and that subjects with plaque erosion had greater evidence of subacute thrombus.</p>","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11413641/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142333630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of acute coronary syndrome on early in-stent neoatherosclerosis as shown by optical coherence tomography. 光学相干断层扫描显示急性冠状动脉综合征对支架内早期新动脉硬化的影响。
AsiaIntervention Pub Date : 2024-09-27 eCollection Date: 2024-09-01 DOI: 10.4244/AIJ-D-24-00021
Kazuhiro Nakao, Takanori Yamazaki, Naoki Fujisawa, Yusuke Kure, Tomohiro Yamaguchi, Shunsuke Kagawa, Takenobu Shimada, Atsushi Shibata, Asahiro Ito, Kenichiro Otsuka, Yasuhiro Izumiya, Daiju Fukuda
{"title":"Impact of acute coronary syndrome on early in-stent neoatherosclerosis as shown by optical coherence tomography.","authors":"Kazuhiro Nakao, Takanori Yamazaki, Naoki Fujisawa, Yusuke Kure, Tomohiro Yamaguchi, Shunsuke Kagawa, Takenobu Shimada, Atsushi Shibata, Asahiro Ito, Kenichiro Otsuka, Yasuhiro Izumiya, Daiju Fukuda","doi":"10.4244/AIJ-D-24-00021","DOIUrl":"https://doi.org/10.4244/AIJ-D-24-00021","url":null,"abstract":"<p><strong>Background: </strong>Patients with acute coronary syndrome (ACS) have a higher risk of requiring target vessel revascularisation after percutaneous coronary intervention (PCI) than patients with stable angina. Neoatherosclerosis is a significant risk factor for very late stent thrombosis, and the presence of neoatherosclerosis is independently associated with major adverse cardiac events.</p><p><strong>Aims: </strong>In this study, we used optical coherence tomography (OCT) to investigate the impact of ACS on neoatherosclerosis within 1 year after PCI.</p><p><strong>Methods: </strong>We investigated 102 patients (122 lesions) who had undergone PCI using a second-generation drug-eluting stent (DES) from March 2017 to November 2020 and were followed up with OCT within 1 year. The patients were categorised into the ACS group or non-ACS group according to their clinical findings at the time of target lesion treatment. We used OCT to investigate the presence of neoatherosclerosis.</p><p><strong>Results: </strong>The ACS group comprised 23 (22.5%) patients. There were no differences in the patients' clinical characteristics between the groups. The total stent length tended to be shorter in the ACS group than in the non-ACS group (24 mm vs 32 mm, respectively; p=0.09), but this difference was not statistically significant. The median duration from PCI was 290 days. Neoatherosclerosis was more frequent in ACS lesions (39% vs 4%; p<0.01), and implantation of a DES in ACS lesions was an independent predictor of neoatherosclerosis occurrence (odds ratio 9.70; p<0.01).</p><p><strong>Conclusions: </strong>This observational study using OCT indicates that stenting for ACS lesions is associated with early in-stent neoatherosclerosis.</p>","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11413567/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142333629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical safety and performance of the world's thinnest-strut Evermine50 everolimus-eluting stent: a 24-month follow-up of the Evermine 50 EES - 1 study. 全球最薄支架 Evermine50 依维莫司洗脱支架的临床安全性和性能:Evermine 50 EES - 1 研究的 24 个月随访。
AsiaIntervention Pub Date : 2024-09-27 eCollection Date: 2024-09-01 DOI: 10.4244/AIJ-D-24-00009
Sivaprasad Kunjukrishnapilla, Jaspal Arneja, Dilip Kumar, Parneesh Arora, Raghu R Thagachagere, Manohar Ganesan, Deepak Davidson, Sanjeeb Roy, Subhash Chandra, Ashokkumar Thakkar
{"title":"Clinical safety and performance of the world's thinnest-strut Evermine50 everolimus-eluting stent: a 24-month follow-up of the Evermine 50 EES - 1 study.","authors":"Sivaprasad Kunjukrishnapilla, Jaspal Arneja, Dilip Kumar, Parneesh Arora, Raghu R Thagachagere, Manohar Ganesan, Deepak Davidson, Sanjeeb Roy, Subhash Chandra, Ashokkumar Thakkar","doi":"10.4244/AIJ-D-24-00009","DOIUrl":"https://doi.org/10.4244/AIJ-D-24-00009","url":null,"abstract":"<p><strong>Background: </strong>Ultrathin-strut stents are considered the future of percutaneous coronary intervention for treating coronary artery disease (CAD). These drug-eluting stents with biodegradable-polymer technology have the potential to improve clinical outcomes in CAD patients.</p><p><strong>Aims: </strong>This study aimed to evaluate the safety and performance of newer-generation ultrathin-strut (50 µm) Evermine50 everolimus-eluting stents (EES) in patients with single or multiple long lesions.</p><p><strong>Methods: </strong>This is a prospective, single-arm, multicentre study conducted in India that enrolled 118 patients with <i>de novo</i> coronary lesions. The endpoints were defined based on the major adverse cardiac events (MACE; composite of cardiac death, myocardial infarction [MI] and clinically driven target lesion revascularisation) up to 24-month follow-up. A subset of patients (n=21) underwent angiographic follow-up for a mean follow-up period of 12 mon.</p><p><strong>Results: </strong>A total of 138 lesions were successfully treated in 118 patients, the majority of whom were males (80.51%). The average stent length and diameter deployed were 26.02±9.24 mm and 2.97±0.36 mm, respectively. The results exhibited low MACE at 24-month follow-up (0.87%) with no stent thrombosis and 1 death (0.87%, which was cardiac). The core lab angiographic assessment showed in-segment and in-device late lumen loss of 0.12±0.31 mm and 0.17±0.31 mm, respectively, at a mean follow-up of 12 months, with clinically acceptable outcomes.</p><p><strong>Conclusions: </strong>The Evermine50 EES showed satisfactory primary clinical as well as angiographic outcomes, reaffirming the safety and performance of the world's thinnest-strut stent by exhibiting low rates of MACE at 24-month follow-up with an absence of any stent thrombosis and MI. Clinical Trials Registry-India (CTRI) number: CTRI/2017/02/007781.</p>","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11413568/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142333626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Less metal - the latest evolution in PCI. 减少金属含量--PCI 的最新发展。
AsiaIntervention Pub Date : 2024-09-27 eCollection Date: 2024-09-01 DOI: 10.4244/AIJ-E-24-00004
Simon Eccleshall, Bruno Scheller
{"title":"Less metal - the latest evolution in PCI.","authors":"Simon Eccleshall, Bruno Scheller","doi":"10.4244/AIJ-E-24-00004","DOIUrl":"https://doi.org/10.4244/AIJ-E-24-00004","url":null,"abstract":"","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11413634/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142336714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accuracy of machine learning in predicting outcomes post-percutaneous coronary intervention: a systematic review. 机器学习在预测经皮冠状动脉介入术后结果方面的准确性:系统综述。
AsiaIntervention Pub Date : 2024-09-27 eCollection Date: 2024-09-01 DOI: 10.4244/AIJ-D-23-00023
Caitlin Fern Wee, Claire Jing-Wen Tan, Chun En Yau, Yao Hao Teo, Rachel Go, Yao Neng Teo, Benjamin Kye Jyn, Nicholas L Syn, Hui-Wen Sim, Jason Z Chen, Raymond C C Wong, James W Yip, Huay-Cheem Tan, Tiong-Cheng Yeo, Ping Chai, Tony Y W Li, Wesley L Yeung, Andie H Djohan, Ching-Hui Sia
{"title":"Accuracy of machine learning in predicting outcomes post-percutaneous coronary intervention: a systematic review.","authors":"Caitlin Fern Wee, Claire Jing-Wen Tan, Chun En Yau, Yao Hao Teo, Rachel Go, Yao Neng Teo, Benjamin Kye Jyn, Nicholas L Syn, Hui-Wen Sim, Jason Z Chen, Raymond C C Wong, James W Yip, Huay-Cheem Tan, Tiong-Cheng Yeo, Ping Chai, Tony Y W Li, Wesley L Yeung, Andie H Djohan, Ching-Hui Sia","doi":"10.4244/AIJ-D-23-00023","DOIUrl":"https://doi.org/10.4244/AIJ-D-23-00023","url":null,"abstract":"<p><strong>Background: </strong>Recent studies have shown potential in introducing machine learning (ML) algorithms to predict outcomes post-percutaneous coronary intervention (PCI).</p><p><strong>Aims: </strong>We aimed to critically appraise current ML models' effectiveness as clinical tools to predict outcomes post-PCI.</p><p><strong>Methods: </strong>Searches of four databases were conducted for articles published from the database inception date to 29 May 2021. Studies using ML to predict outcomes post-PCI were included. For individual post-PCI outcomes, measures of diagnostic accuracy were extracted. An adapted checklist comprising existing frameworks for new risk markers, diagnostic accuracy, prognostic tools and ML was used to critically appraise the included studies along the stages of the translational pathway: development, validation, and impact. Quality of training data and methods of dealing with missing data were evaluated.</p><p><strong>Results: </strong>Twelve cohorts from 11 studies were included with a total of 4,943,425 patients. ML models performed with high diagnostic accuracy. However, there are concerns over the development of the ML models. Methods of dealing with missing data were problematic. Four studies did not discuss how missing data were handled. One study removed patients if any of the predictor variable data points were missing. Moreover, at the validation stage, only three studies externally validated the models presented. There could be concerns over the applicability of these models. None of the studies discussed the cost-effectiveness of implementing the models.</p><p><strong>Conclusions: </strong>ML models show promise as a useful clinical adjunct to traditional risk stratification scores in predicting outcomes post-PCI. However, significant challenges need to be addressed before ML can be integrated into clinical practice.</p>","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11413637/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142333625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Less is more: a new "thin-king" for DES? 少即是多:DES 的新 "瘦身王"?
AsiaIntervention Pub Date : 2024-09-27 eCollection Date: 2024-09-01 DOI: 10.4244/AIJ-E-24-00005
Azfar G Zaman, Abhishek Kumar
{"title":"Less is more: a new \"thin-king\" for DES?","authors":"Azfar G Zaman, Abhishek Kumar","doi":"10.4244/AIJ-E-24-00005","DOIUrl":"https://doi.org/10.4244/AIJ-E-24-00005","url":null,"abstract":"","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11413633/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142336713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter: Deciphering a "curious" coronary artery anatomy. 信:解密 "奇特 "的冠状动脉解剖。
AsiaIntervention Pub Date : 2024-09-27 eCollection Date: 2024-09-01 DOI: 10.4244/AIJ-D-24-00015
Andreas Y Andreou
{"title":"Letter: Deciphering a \"curious\" coronary artery anatomy.","authors":"Andreas Y Andreou","doi":"10.4244/AIJ-D-24-00015","DOIUrl":"https://doi.org/10.4244/AIJ-D-24-00015","url":null,"abstract":"","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11413565/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142336715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of physiology in the management of multivessel disease among patients with acute coronary syndrome. 生理学在急性冠状动脉综合征患者多血管疾病治疗中的作用。
AsiaIntervention Pub Date : 2024-09-27 eCollection Date: 2024-09-01 DOI: 10.4244/AIJ-D-24-00051
Nandine Ganzorig, Graziella Pompei, Kenny Jenkins, Wanqi Wang, Francesca Rubino, Kieran Gill, Vijay Kunadian
{"title":"Role of physiology in the management of multivessel disease among patients with acute coronary syndrome.","authors":"Nandine Ganzorig, Graziella Pompei, Kenny Jenkins, Wanqi Wang, Francesca Rubino, Kieran Gill, Vijay Kunadian","doi":"10.4244/AIJ-D-24-00051","DOIUrl":"https://doi.org/10.4244/AIJ-D-24-00051","url":null,"abstract":"<p><p>Multivessel coronary artery disease (CAD), defined as ≥50% stenosis in 2 or more epicardial arteries, is associated with a high burden of morbidity and mortality in acute coronary syndrome (ACS) patients. A salient challenge for managing this cohort is selecting the optimal revascularisation strategy, for which the use of coronary physiology has been increasingly recognised. Fractional flow reserve (FFR) is an invasive, pressure wire-based, physiological index measuring the functional significance of coronary lesions. Understanding this can help practitioners evaluate which lesions could induce myocardial ischaemia and, thus, decide which vessels require urgent revascularisation. Non-hyperaemic physiology-based indices, such as instantaneous wave-free ratio (iFR), provide valid alternatives to FFR. While FFR and iFR are recommended by international guidelines in stable CAD, there is ongoing discussion regarding the role of physiology in patients with ACS and multivessel disease (MVD); growing evidence supports FFR use in the latter. Compelling findings show FFR-guided complete percutaneous coronary intervention (PCI) can reduce adverse cardiovascular events, mortality, and repeat revascularisations in ACS and MVD patients compared to angiography-based PCI. However, FFR is limited in identifying non-flow-limiting vulnerable plaques, which can disadvantage high-risk patients. Here, integrating coronary physiology assessment with intracoronary imaging in decision-making can improve outcomes and quality of life. Further research into novel physiology-based tools in ACS and MVD is needed. This review aims to highlight the key evidence surrounding the role of FFR and other functional indices in guiding PCI strategy in ACS and MVD patients.</p>","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11413640/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142333632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A hospital lipid-lowering protocol improves 2-year clinical outcomes in patients with acute coronary syndrome. 医院降脂方案可改善急性冠状动脉综合征患者的 2 年临床疗效。
AsiaIntervention Pub Date : 2024-09-27 eCollection Date: 2024-09-01 DOI: 10.4244/AIJ-D-23-00056
Sho Nakao, Takayuki Ishihara, Takuya Tsujimura, Osamu Iida, Yosuke Hata, Taku Toyoshima, Naoko Higashino, Masaya Kusuda, Toshiaki Mano
{"title":"A hospital lipid-lowering protocol improves 2-year clinical outcomes in patients with acute coronary syndrome.","authors":"Sho Nakao, Takayuki Ishihara, Takuya Tsujimura, Osamu Iida, Yosuke Hata, Taku Toyoshima, Naoko Higashino, Masaya Kusuda, Toshiaki Mano","doi":"10.4244/AIJ-D-23-00056","DOIUrl":"https://doi.org/10.4244/AIJ-D-23-00056","url":null,"abstract":"<p><strong>Background: </strong>Although mortality after acute coronary syndrome (ACS) has improved in the acute phase, cardiovascular events occur at a certain frequency in the chronic phase. A hospital lipid-lowering protocol (HLP) could be effective in providing optimal lipid-lowering therapy to improve long-term clinical outcomes after ACS.</p><p><strong>Aims: </strong>This study investigated the impact of HLP on clinical outcomes in patients with ACS.</p><p><strong>Methods: </strong>We retrospectively analysed 1,114 ACS patients who had undergone successful percutaneous coronary intervention between November 2011 and June 2021. In December 2018, we introduced a HLP that included the prescription of the maximum tolerated dose of statin, ezetimibe, and eicosapentaenoic acid after ACS treatment. We compared 2-year clinical outcomes before (control group: 791 patients) and after the HLP's introduction (HLP group: 323 patients). The primary outcome was the non-target vessel revascularisation (non-TVR) rate. A multivariate Cox proportional hazard model and inverse probability weighting (IPW) based on the propensity score were used to evaluate the effect of HLP on the outcomes.</p><p><strong>Results: </strong>The cumulative 2-year non-TVR incidence was significantly lower in the HLP group than in the control group (8.5% vs 13.8%; p=0.019). Multivariable analysis revealed non-TVR risk was significantly lower in the HLP group than in the control group (adjusted hazard ratio [aHR]: 0.637 [95% confidence interval [CI]: 0.416-0.975]; p=0.038). The IPW analysis confirmed a significant association between the HLP and a lower non-TVR risk (aHR: 0.544 [95% CI: 0.350-0.847]; p=0.007).</p><p><strong>Conclusions: </strong>Implementing HLP for ACS patients improved the 2-year clinical outcome.</p>","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11413639/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142333624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信